Prot #CD07_TNBC: A Phase Ib/II Study of Leronlimab (PRO 140) Combined with Carboplatin in Patients with CCR5+ Metastatic Triple-Negative Breast Cancer (mTNBC)

  • Cristofanilli, Massimo (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date7/8/19 → 7/8/22

Funding

  • Amarex Clinical Research ((OE) Prot #CD07_TNBC // (OE) Prot #CD07_TNBC)
  • CytoDyn Inc. ((OE) Prot #CD07_TNBC // (OE) Prot #CD07_TNBC)